Search for: "Centre Manufacturing Company, Inc. v. the United States"
Results 21 - 40
of 44
Sorted by Relevance
|
Sort by Date
14 Dec 2021, 2:00 pm
(Note: in July 2018 – almost three years after the shareholder class actions commenced – the company changed its name to Bausch Health Companies, Inc.) [read post]
13 Oct 2008, 12:12 pm
ECJ clarifies rules relating to notice: K-Swiss Inc v OHIM (Class 46) EU Competitiveness Council resolution against counterfeiting and piracy (Class 46) EU states back three-point anti-piracy plan (Managing Intellectual Property) Fuel cells and wind power lead European patent filings for clean energy technology (Green Patent Blog) More non-minor geographical indicator (GI) amendments published (Class 46) No sign of any Community patent progress, despite Verheugen's… [read post]
24 Apr 2009, 10:00 am
(IPEG) Denmark Revamp of Danish PTO English language site – invitation for help from users (Class 46) Europe ECJ gives Copad ruling on exhaustion and luxury goods; interpretation of Article 8(2) leads to new questions: Copad SA v Christian Dior couture SA, Vincent Gladel, as liquidator of Société industrielle lingerie (Class 46) (IPKat) Anti-patent rally; criticism of practice of patenting biological processes - Munich (Intellectual… [read post]
21 Dec 2009, 5:24 am
Mars (IP Dragon) Colombia An illegal whisky gives you more than a dishonest hangover – seizure of counterfeit whisky bottled in bottles purchased from recycling centres (IP tango) Europe ECJ to decide on ‘manufacturing fiction’ under Counterfeit Good Regulation (EPLAW) ECJ: ‘Fair compensation’ referral: Entidad de Gestión de Derechos de los Productores Audiovisuales (EGEDA) v Magnatrading S.L (1709 Copyright Blog) Latest… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
20 Feb 2009, 5:00 am
(Spicy IP) Copyright in characters – III – Delhi High Court decision in Raja Pocket Books v Radha Pocket Books (Spicy IP) Kenya Anti-Counterfeit Bill 2008 passed (Afro-IP) Kenya’s new anti-counterfeit legislation discussion (Afro-IP) Kuwait Kuwait adopts international classes 42-45 (Kuwaitmark) Macedonia New Industrial Property Law (Class 46) Nigeria Court moves from Uyo to continue proceedings in New York in… [read post]
9 Apr 2009, 9:27 am
(Promote the Progress) N D Illinois one step closer to adopting patent rules (Peter Zura's 271 Patent Blog) Innovate Texas Foundation launched to accelerate state’s IP commercialisation (Technology Transfer Tactics) Special Masters a [read post]
27 Feb 2009, 7:00 am
(The IP Factor) Uganda Anti-counterfeits conference held in Kampala (Afro-IP) United Kingdom IP rights in the Court of Appeal, but not as we know them...: Office of Communications v Information Commissioner (IPKat) IPO review of practice before Patent Tribunal (PatLit) Employee inventor compensation: an expensive pastime? [read post]
19 Sep 2008, 6:00 pm
: (Danny Weitzner - Open Internet Policy), United States: How many lines is de minimis? [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
27 Dec 2021, 7:02 am
Allegedly, “Oaktree Medical Centre P.C. [read post]
18 Apr 2008, 2:00 am
, Global Global - General Candidates for post of WIPO Director General present their platforms: (WIPO), IP is not a thing: (Dilanchian), FOSS adoption and consumer welfare: (IPcentral) Global - Trade Marks / Domain Names / Brands Manufacturers becoming brand licensing companies: (IP ThinkTank), Anti-Counterfeiting Trade Agreement moves forward: (Michael Geist) Global - Patents Office Open XML voted to become official standard, so out of… [read post]
4 Jun 2019, 9:30 pm
I have been extremely lucky to be a part of Davis Centre this year. [read post]
5 Dec 2021, 4:39 pm
Summary Judgement was granted to the defendants in the case of Abulrazaq v The Trustees of the Exeter Mosque and Cultural centre [2021] EWHC 3252 (QB). [read post]
9 May 2008, 10:30 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Order to transfer myspace.co.uk to MySpace overturned: (Out-Law), (IMPACT), New branding scheme for Ethiopian coffees: (Afro-IP), (IP finance), (IPKat), USPTO to appeal Tafas/GSK v Dudas: (Patent Docs), (Patently-O), (PLI), (Patent Baristas), (Managing Intellectual Property), (IP Law360), (Patent Prospector), (Ladas & Parry),… [read post]
17 Jun 2020, 1:12 am
Inghams sought to restrain the referral to arbitration and failed at first instance; see Inghams Enterprises Pty Ltd v Hannigan [2019] NSWSC 1186. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
22 Oct 2020, 4:00 am
The recent decision of the Supreme Court of Canada in, R. v. [read post]
24 Jul 2023, 3:38 am
Last Week in the Courts On Monday 17 July 2023 Nicklin J, sitting at the Port Talbot Justice Centre, heard the case of Corey Lee Styles v South Wales Police [2023] EWHC 1835 (KB). [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from… [read post]
